AIM: To measure the dose distribution, related to the treatment planning calculations, in the contralateral mammary gland of breast cancer patients treated with accelerated hypofractionated 3-dimensional conformal radiotherapy. METHODS: Thirty-four prospectively selected female patients with right breast cancer (pN0, negative surgical margins) were treated with breast-conserving surgery. A total dose of 42.5 Gy (2.66 Gy/fraction) was prescribed; it was requested that planning target volumes be covered by the 95% isodose line. The contralateral mammary gland was defined on CT simulation. The dose received was evaluated by dose volume histograms. RESULTS: The measured contralateral breast doses were: (1) Dose maximum: 290-448 cGy [Equivalent (Eq) 337-522 cGy]; (2) Mean dose: 45-70 cGy (Eq 524-815 cGy); and (3) Median dose: 29-47 cGy (337-547 cGy) for total primary breast dose of 42.5 Gy in 16 equal fractions. The spearman rho correlation showed statistical significance between the contralateral breast volume and maximum dose (P = 0.0292), as well as mean dose (P = 0.0025) and median dose (P = 0.046) to the breast. CONCLUSION: Minimizing the dose to the contralateral breast has to be one of the priorities of the radiation oncologist when using short schedules because of the radiosensitivity of this organ at risk. Further study is necessary to assess the long-term clinical impact of this schedule.
AIM: To measure the dose distribution, related to the treatment planning calculations, in the contralateral mammary gland of breast cancerpatients treated with accelerated hypofractionated 3-dimensional conformal radiotherapy. METHODS: Thirty-four prospectively selected female patients with right breast cancer (pN0, negative surgical margins) were treated with breast-conserving surgery. A total dose of 42.5 Gy (2.66 Gy/fraction) was prescribed; it was requested that planning target volumes be covered by the 95% isodose line. The contralateral mammary gland was defined on CT simulation. The dose received was evaluated by dose volume histograms. RESULTS: The measured contralateral breast doses were: (1) Dose maximum: 290-448 cGy [Equivalent (Eq) 337-522 cGy]; (2) Mean dose: 45-70 cGy (Eq 524-815 cGy); and (3) Median dose: 29-47 cGy (337-547 cGy) for total primary breast dose of 42.5 Gy in 16 equal fractions. The spearman rho correlation showed statistical significance between the contralateral breast volume and maximum dose (P = 0.0292), as well as mean dose (P = 0.0025) and median dose (P = 0.046) to the breast. CONCLUSION: Minimizing the dose to the contralateral breast has to be one of the priorities of the radiation oncologist when using short schedules because of the radiosensitivity of this organ at risk. Further study is necessary to assess the long-term clinical impact of this schedule.
Entities:
Keywords:
Breast cancer; Contralateral breast; Dose calculation; Hypofractionation
Authors: Ajay K Bhatnagar; Edward Brandner; Deborah Sonnik; Andrew Wu; Shalom Kalnicki; Melvin Deutsch; Dwight E Heron Journal: Breast Cancer Res Treat Date: 2005-10-22 Impact factor: 4.872
Authors: Jessica R Hiatt; Suzanne B Evans; Lori Lyn Price; Gene A Cardarelli; Thomas A Dipetrillo; David E Wazer Journal: Int J Radiat Oncol Biol Phys Date: 2006-08-01 Impact factor: 7.038
Authors: Timothy Whelan; Robert MacKenzie; Jim Julian; Mark Levine; Wendy Shelley; Laval Grimard; Barbara Lada; Himu Lukka; Francisco Perera; Anthony Fyles; Ethan Laukkanen; Sunil Gulavita; Veronique Benk; Barbara Szechtman Journal: J Natl Cancer Inst Date: 2002-08-07 Impact factor: 13.506
Authors: Michael I Koukourakis; Pelagia G Tsoutsou; Ioannis M Abatzoglou; Kyriaki Sismanidou; Alexandra Giatromanolaki; Efthimios Sivridis Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-06 Impact factor: 7.038
Authors: Elantholi P Saibishkumar; Marc A MacKenzie; Diane Severin; Alina Mihai; John Hanson; Helene Daly; Gino Fallone; Matthew B Parliament; Bassam S Abdulkarim Journal: Int J Radiat Oncol Biol Phys Date: 2007-09-19 Impact factor: 7.038
Authors: Vassilis Kouloulias; Eftychia Mosa; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Kalliopi Platoni; Christos Antypas; George Kyrgias; Maria Tolia; Christos Papadimitriou; Amanda Psyrri; George Patatoukas; Maria Dilvoi; Christina Armpilia; Kyriaki Theodorou; Maria-Aggeliki Kalogeridi; Ivelina Beli; John Kouvaris; Nikolaos Kelekis Journal: Breast Care (Basel) Date: 2016-09-28 Impact factor: 2.860